Experts Say FDA Isn’t Ready For LDT Application Deluge

Former FDA officials and Congressional staffers speaking at a FDLI panel say that the FDA isn’t prepared for the number of applications that will arise from the new proposed LDT rules.

• Source: Shutterstock

The US Food and Drug Administration is unprepared for the wave of applications it will receive as a part of its proposed rule to better regulate laboratory-developed tests (LDT).

More from In Vitro Diagnostics

More from Diagnostics